Breaking News Instant updates and real-time market news.

ELAN

Elanco

$29.75

-0.925 (-3.02%)

06:34
08/13/19
08/13
06:34
08/13/19
06:34

Elanco narrows FY19 adjusted EPS view to $1.04-$1.10 from $1.02-$1.12

Narrows FY19 revenue view to $3.080B-$3.120B from $3.080B-$3.140B. Consensus is for FY19 EPS $1.09 andd for revenue $3.11B. Elanco updated its FY19 guidance to reflect underlying market dynamics in our business, primarily the increased headwind from African Swine Fever and anticipated supply disruption of certain injectable cattle products offset by the positive impact from business development actions. The company is lowering the top end of the revenue range by $20M, which reflects up to 4% growth in Core Revenue, excluding the impact of foreign exchange rates.

  • 13

    Aug

  • 09

    Sep

ELAN Elanco
$29.75

-0.925 (-3.02%)

05/23/19
GUGG
05/23/19
INITIATION
GUGG
Neutral
Elanco initiated with a Neutral at Guggenheim
Guggenheim analyst David Westenberg initiated coverage on 10 companies in animal health, starting Elanco with a Neutral rating. He sees limited upside potential from Credelio and Interceptor Plus and cites limited visibility into the company's pipeline, though Westenberg also expects continued strong sales of Galliprant and thinks margin expansion goals are "mostly achievable."
05/23/19
05/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Elanco (ELAN) initiated with a Neutral at Guggenheim. 2. Cooper Tire (CTB) initiated with an Overweight at KeyBanc while Goodyear Tire (GT) was initiated with a Sector Weight. 3. SciPlay (SCPL) initiated with a Buy at Craig-Hallum and an Overweight at Stephens. 4. Target Hospitality (TH) initiated with an Outperform at Credit Suisse and Oppenheimer. 5. Allogene Therapeutics (ALLO) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
EVER
07/08/19
NO CHANGE
EVER
Outperform
First generic Rumensin approval earlier than Elanco expected, says Evercore ISI
Evercore ISI analyst Umer Raffat notes that the first generic for Rumensin has been approved, earlier than expected by Elanco (ELAN), which had modeled a possible generic entry in 2020. Many investors had assumed that Zoetis (ZTS) "may be the first generic" but it was "actually a Hungarian company, Huvepharma," the analyst noted. Raffat also highlighted that Rumensin is Elanco's biggest product. The analyst has an Outperform rating on Elanco's shares.
07/10/19
WBLR
07/10/19
NO CHANGE
WBLR
Market Perform
Elanco combination with Bayer unlikely for many reasons, says William Blair
Shares of Elanco Animal Health (ELAN) have been unusually volatility over the past two days, William Blair analyst John Kreger tells investors in a research note. On Monday, the FDA approved a generic version of the company's largest product, Rumensin, and yesterday, the media reported speculation that Bayer (BAYRY) has approached Elanco about combining their animal health businesses, the analyst explains. He believes that while a negative development, the Rumensin generic had been expected and thus does not change his modeling assumptions. The Bayer speculation is more surprising but does not seem likely to happen "for a number of reasons," says Kreger. Elanco's largest challenge is bolstering its organic revenue growth, and buying a large company that is growing at a slower pace would only add to this challenge, according the analyst. Further, Elanco has committed to deleverage its balance sheet in the coming year, he adds. And lastly, Kreger believes there could be antitrust challenges from such a large combination. He keeps a Market Perform rating on Elanco shares.

TODAY'S FREE FLY STORIES

ONE

OneSmart

$7.03

-0.355 (-4.81%)

05:36
08/19/19
08/19
05:36
08/19/19
05:36
Hot Stocks
OneSmart announces CEO share purchase plan »

OneSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$37.05

1.69 (4.78%)

05:34
08/19/19
08/19
05:34
08/19/19
05:34
Earnings
Breaking Earnings news story on Weibo »

Weibo sees Q3 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

WB

Weibo

$37.05

1.69 (4.78%)

05:34
08/19/19
08/19
05:34
08/19/19
05:34
Earnings
Weibo reports Q2 EPS 68c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SINA

Sina

$37.66

1.97 (5.52%)

05:32
08/19/19
08/19
05:32
08/19/19
05:32
Earnings
Sina reports Q2 EPS 76c, consensus 47c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

05:25
08/19/19
08/19
05:25
08/19/19
05:25
General news
FX Action: The yen has nudged lower »

FX Action: The yen has…

05:20
08/19/19
08/19
05:20
08/19/19
05:20
General news
FX Action: The yen has nudged lower »

FX Action: The yen has…

TWTR

Twitter

$40.58

0.47 (1.17%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Twitter management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 20

    Aug

  • 24

    Sep

AVY

Avery Dennison

$113.94

2.305 (2.06%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Avery Dennison management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

CHH

Choice Hotels

$88.24

0.7 (0.80%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Choice Hotels management to meet with Morgan Stanley »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

PAYS

Paysign

$13.94

0.12 (0.87%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Recommendations
Paysign analyst commentary  »

Paysign management to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

APHA

Aphria

$6.17

0.23 (3.87%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Aphria management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

MCO

Moody's

$214.29

4.42 (2.11%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Moody's management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

NCMGY

Newcrest Mining

$0.00

(0.00%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Newcrest Mining management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

NPO

EnPro

$61.93

2.13 (3.56%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
EnPro management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

RMD

ResMed

$134.45

2.06 (1.56%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
ResMed management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 26

    Aug

  • 05

    Nov

  • 06

    Nov

ZNGA

Zynga

$5.56

0.025 (0.45%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Zynga management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 13

    Nov

CCMP

Cabot Microelectronics

$122.73

4.24 (3.58%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Cabot Microelectronics management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

04:55
08/19/19
08/19
04:55
08/19/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

QMCO

Quantum

$0.00

(0.00%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Quantum management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 12

    Sep

GKOS

Glaukos

$63.02

2.385 (3.93%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Glaukos management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 26

    Aug

  • 04

    Sep

  • 13

    Nov

04:55
08/19/19
08/19
04:55
08/19/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

BCEI

Bonanza Creek

$22.76

1.61 (7.61%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Bonanza Creek management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

FFIN

First Financial

$31.15

0.78 (2.57%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Recommendations
First Financial analyst commentary  »

First Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

SF

Stifel Financial

$52.18

0.925 (1.80%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
Stifel Financial management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

AU

AngloGold

$21.04

0.7 (3.44%)

04:55
08/19/19
08/19
04:55
08/19/19
04:55
Conference/Events
AngloGold management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.